Open programs1
Investigator-Initiated Studies (IIS) - Sarepta Therapeutics
Sarepta Therapeutics funds investigator-initiated studies (IIS) to support independent clinical or non-clinical research that advances precision genetic medicine for rare neuromuscular diseases, providing financial and/or material support aligned with its therapeutic focus.
- Deadline
- Not listed
- Amount
- Not listed
Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.